AURA coordinates data from a range of sources to provide a comprehensive and integrated picture of patterns and trends of AMR and antimicrobial use across Australia. A number of surveillance programs initially provided the foundation for establishing the AURA Surveillance System; these included:
- Australian Group on Antimicrobial Resistance
- National Antimicrobial Prescribing Survey
- National Antimicrobial Utilisation Surveillance Program.
In addition, the Commission has had the support of Queensland Health in the development of the Australia Passive AMR Surveillance (APAS) system, through the use of the OrgTRx System as the IT infrastructure for the system.
Data and reports are gathered from the following organisations and programs to provide comprehensive surveillance:
- The National Neisseria Network
- The National Notifiable Diseases Surveillance System
- The Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits Scheme (RPBS)
- The NPS MedicineWise MedicineInsight program
- Sullivan Nicolaides Pathology on rates of AMR from selected community and private hospital settings.
In 2016, the Commission also established the National Alert System for Critical Antimicrobial Resistances (CARAlert) to provide information on those priority organisms that are resistant to last-line antimicrobials through targeted surveillance data.